MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA

Journal of Neuroscience

Volumn 34, Issue 38, 2014, Pages 12725-12737

  Choi, Doo Chul ^a   Chae, Yoon Jee ^a   Kabaria, Savan ^a   Chaudhuri, Amrita Datta ^a   Jain, Mohit Raja ^b   Li, Hong ^b   Maral Mouradian, M ^a   Junn, Eunsung ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b The State University of New Jersey   (United States)

Author keywords

Cell death; microRNA 7; MPP; NF B; Parkinson s disease; RelA

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LENTIVIRUS VECTOR; MICRORNA; MICRORNA 7; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TRANSCRIPTION FACTOR RELA; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; ALPHA SYNUCLEIN; CARISOPRODOL; MIRN7 MICRORNA, HUMAN; NEUROPROTECTIVE AGENT; RELA PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BIOINFORMATICS; BRAIN CELL; CELL CULTURE; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MOUSE; NERVE FIBER GROWTH; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; RNA ISOLATION; SUBSTANTIA NIGRA; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DOPAMINERGIC NERVE CELL; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; MICRORNA-7; MPP+; NERVE CELL; NF-ΚB; PHYSIOLOGY;

CELL DEATH; MICRORNA-7; MPP+; NF-ΚB; PARKINSON'S DISEASE; RELA;

1-METHYL-4-PHENYLPYRIDINIUM; ALPHA-SYNUCLEIN; ANIMALS; CELL DEATH; CELLS, CULTURED; DOPAMINERGIC NEURONS; DOWN-REGULATION; HUMANS; MICE; MICRORNAS; NEURONS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; PARKINSON DISEASE, SECONDARY; SUBSTANTIA NIGRA; TRANSCRIPTION FACTOR RELA; TRANSFECTION;

EID: 84907148389     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0985-14.2014     Document Type: Article

References (43)

1. Ashburner BP, Westerheide SD, Baldwin AS Jr (2001) The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21:7065-7077.CrossRef Medline
2. Bilen J, Liu N, Burnett BG, Pittman RN, Bonini NM (2006) MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol Cell 24:157-163.CrossRef Medline
3. Campbell KJ, Perkins ND (2004) Post-translational modification of RelA(p65) NF-kappaB. Biochem Soc Trans 32:1087-1089.CrossRef Medline
4. Campbell KJ, Rocha S, Perkins ND (2004) Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell 13:853-865.CrossRef Medline
5. Chaudhuri AD, Yelamanchili SV, Fox HS (2013) Combined fluorescent in situ hybridization for detection of microRNAs and immunofluorescent labeling for cell-type markers. Front Cell Neurosci 7:160.CrossRef Medline
6. Chou YT, Lin HH, Lien YC, Wang YH, Hong CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, Chen HC, Yeh SD, Wu CW (2010) EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Res 70:8822-8831.CrossRef Medline
7. Cookson MR, Bandmann O (2010) Parkinson’s disease: insights from pathways. Hum Mol Genet 19:R21-R27.CrossRef Medline
8. Daimon E, Shibukawa Y, Wada Y (2013) Calponin 3 regulates stress fiber formation in dermal fibroblasts during wound healing. Arch Dermatol Res 305:571-584.CrossRef Medline
9. Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson’s disease. J Parkinsons Dis 3:461-491.CrossRef Medline
10. Donato R, Miljan EA, Hines SJ, Aouabdi S, Pollock K, Patel S, Edwards FA, Sinden JD (2007) Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci 8:36.CrossRef Medline
11. Eacker SM, Dawson TM, Dawson VL (2009) Understanding microRNAs in neurodegeneration. Nat Rev Neurosci 10:837-841.CrossRef Medline
12. Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, Ghosh S, Mosley RL, Gendelman HE, Pahan K (2007) Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease. Proc Natl Acad Sci U S A 104:18754-18759.CrossRef Medline
13. Halvorsen EM, Dennis J, Keeney P, Sturgill TW, Tuttle JB, Bennett JB Jr (2002) Methylpyridinium (MPP())-and nerve growth factor-induced changes in pro-and anti-apoptotic signaling pathways in SH-SY5Y neuroblastoma cells. Brain Res 952:98-110.CrossRef Medline
14. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:522-531.CrossRef Medline
15. Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, Hirsch EC (1997) Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc Natl Acad Sci U S A 94:7531-7536.CrossRef Medline
16. Jain MR, Li Q, Liu T, Rinaggio J, Ketkar A, Tournier V, Madura K, Elkabes S, Li H (2012) Proteomic identification of immunoproteasome accumulation in formalin-fixed rodent spinal cords with experimental autoimmune encephalomyelitis. J Proteome Res 11:1791-1803.CrossRef Medline
17. Junn E, Mouradian MM (2012) MicroRNAs in neurodegenerative diseases and their therapeutic potential. Pharmacol Ther 133:142-150.CrossRef Medline
18. Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian MM (2003) Tissue transglutaminase-induced aggregation of alpha-synuclein: implications for Lewy body formation in Parkinson’s disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A 100:2047-2052.CrossRef Medline
19. Junn E, Lee KW, Jeong BS, Chan TW, Im JY, Mouradian MM (2009) Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci U S A 106:13052-13057.CrossRef Medline
20. Karunakaran S, Ravindranath V (2009) Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice: implication in Parkinson’s disease. J Neurochem 109:1791-1799.CrossRef Medline
21. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A (2007) A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317:1220-1224.CrossRef Medline
22. Kucharczak J, Simmons MJ, Fan Y, Gélinas C (2003) To be, or not to be: NF-kappaB is the answer—role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 22:8961-8982.CrossRef Medline
23. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Foà R, Schliwka J, Fuchs U, Novosel A, Muller RU, et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401-1414.CrossRef Medline
24. Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46:598-605.CrossRef Medline
25. Lee Y, Samaco RC, Gatchel JR, Thaller C, Orr HT, Zoghbi HY (2008) miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci 11:1137-1139.CrossRef Medline
26. Li Q, Jain MR, Chen W, Li H (2013) A multidimensional approach to an in-depth proteomics analysis of transcriptional regulators in neuroblastoma cells. J Neurosci Methods 216:118-127.CrossRef Medline
27. Liu S, Zhang P, Chen Z, Liu M, Li X, Tang H (2013) MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells. FEBS Lett 587:2247-2253.CrossRef Medline
28. Meijering E, Jacob M, Sarria JC, Steiner P, Hirling H, Unser M (2004) Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry A 58:167-176.CrossRef Medline
29. Moore FB, Baleja JD (2012) Molecular remodeling mechanisms of the neural somatodendritic compartment. Biochim Biophys Acta 1823:1720-1730.CrossRef Medline
30. Oeckinghaus A, Hayden MS, Ghosh S (2011) Crosstalk in NF-kappaB signaling pathways. Nat Immunol 12:695-708.CrossRef Medline
31. Perkins ND (2004) NF-kappaB: tumor promoter or suppressor? Trends Cell Biol 14:64-69.CrossRef Medline
32. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10:1507-1517.CrossRef Medline
33. Sedelis M, Hofele K, Auburger GW, Morgan S, Huston JP, Schwarting RK (2000) MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences. Behav Genet 30:171-182.CrossRef Medline
34. Shibukawa Y, Yamazaki N, Kumasawa K, Daimon E, Tajiri M, Okada Y, Ikawa M, Wada Y (2010) Calponin 3 regulates actin cytoskeleton rearrangement in trophoblastic cell fusion. Mol Biol Cell 21:3973-3984.CrossRef Medline
35. Thomas B, Beal MF (2007) Parkinson’s disease. Hum Mol Genet 16 [Spec. No. 2]:R183-R194.CrossRef Medline
36. Tyler WA, Jain MR, Cifelli SE, Li Q, Ku L, Feng Y, Li H, Wood TL (2011) Proteomic identification of novel targets regulated by the mammalian target of rapamycin pathway during oligodendrocyte differentiation. Glia 59:1754-1769.CrossRef Medline
37. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM (1996) Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274:787-789.CrossRef Medline
38. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S (1995) Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 9:2723-2735.CrossRef Medline
39. Wang CY, Mayo MW, Baldwin AS Jr (1996) TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274: 784-787.CrossRef Medline
40. Wang Y, Liu J, Liu C, Naji A, Stoffers DA (2013) MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic beta-cells. Diabetes 62:887-895.CrossRef Medline
41. Yuan Y, Jin J, Yang B, Zhang W, Hu J, Zhang Y, Chen NH (2008) Overex-pressed alpha-synuclein regulated the nuclear factor-kappaB signal pathway. Cell Mol Neurobiol 28:21-33.CrossRef Medline
42. Yu Z, Ni L, Chen D, Zhang Q, Su Z, Wang Y, Yu W, Wu X, Ye J, Yang S, Lai Y, Li X (2013) Identification of miR-7 as an oncogene in renal cell carcinoma. J Mol Histol 44:669-677.CrossRef Medline
43. Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok MT, Wang H, Chen J, Ng SS, Chen M, Sung JJ, Yu J (2013) microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Oncogene 32:5078-5088.CrossRef Medline